Orchid Cellmark (ORCH) Awarded $10M Contract Extension Under Wales Forensic Tender Process

The Street Insider UK
Orchid Cellmark Inc. (Nasdaq: ORCH) today announced it has been awarded two-year extensions to contracts previously awarded under the North West/South West and Wales regional forensic tender process in the U.K. Total estimated annual value of the combined contracts is approximately (U.S.) $10 million (at the current foreign exchange rate).

Comments are closed.